This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Lodz University of Technology, Peptaderm Sp. Z O.o., Vitaerx Pharmaceutical, Inc.. Active years: 2010-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 15 
1 out of 1 
1 out of 1 Years Active: 2010-2019
Title: Michal Zimecki: Innovator in Cyclic Tetrapeptides
Introduction
Michal Zimecki is a notable inventor based in Wroclaw, Poland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cyclic tetrapeptides. With a total of 3 patents to his name, Zimecki's work has the potential to impact therapeutic applications significantly.
Latest Patents
Zimecki's latest patents focus on cyclic tetrapeptides and their therapeutic applications. The patents provide compounds of formula I, wherein k, m, n, p, R, R', R'', R'', R, R, and R are defined in the application. These compounds have various embodiments that are also disclosed, showcasing the versatility and potential of his inventions.
Career Highlights
Throughout his career, Michal Zimecki has worked with prominent organizations, including Vitaerx Pharmaceutical, Inc. and Lodz University of Technology. His experience in these institutions has allowed him to refine his expertise and contribute to innovative research in the pharmaceutical field.
Collaborations
Zimecki has collaborated with notable individuals in his field, including Janusz Zabrocki and Andrzej Kaszuba. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.
Conclusion
In summary, Michal Zimecki is a distinguished inventor whose work on cyclic tetrapeptides has the potential to advance therapeutic applications. His contributions to the pharmaceutical industry are noteworthy, and his collaborations further enhance the impact of his innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile